Literature DB >> 27297464

Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities Study.

Craig D Seaman1, Kristen M George2, Margaret Ragni3, Aaron R Folsom2.   

Abstract

Entities:  

Keywords:  Cardiovascular disease; Von Willebrand disease; Von Willebrand factor

Mesh：

Substances：

Year:  2016        PMID： 27297464      PMCID： PMC5339890          DOI： 10.1016/j.thromres.2016.05.029

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

Review 1.  Von Willebrand factor deficiency and atherosclerosis.

Authors:  K P M van Galen; A Tuinenburg; E M Smeets; R E G Schutgens
Journal:  Blood Rev       Date:  2012-06-19       Impact factor: 8.250

2.  von Willebrand factor and coronary heart disease: prospective study and meta-analysis.

Authors:  P H Whincup; J Danesh; M Walker; L Lennon; A Thomson; P Appleby; A Rumley; G D O Lowe
Journal:  Eur Heart J       Date:  2002-11       Impact factor: 29.983

Review 3.  Cardiovascular risk in patients with hemophilia.

Authors:  Pieter W Kamphuisen; Hugo ten Cate
Journal:  Blood       Date:  2014-01-02       Impact factor: 22.113

Review 4.  von Willebrand factor, endothelial dysfunction, and cardiovascular disease.

Authors:  U M Vischer
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

5.  Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register.

Authors:  C D Seaman; J Yabes; D M Comer; M V Ragni
Journal:  J Thromb Haemost       Date:  2015-10-28       Impact factor: 5.824

6.  Reduced prevalence of arterial thrombosis in von Willebrand disease.

Authors:  Y V Sanders; J Eikenboom; E M de Wee; J G van der Bom; M H Cnossen; M E L Degenaar-Dujardin; K Fijnvandraat; P W Kamphuisen; B A P Laros-van Gorkom; K Meijer; E P Mauser-Bunschoten; F W G Leebeek
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

Review 7.  Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.

Authors:  Michelle A H Sonneveld; Moniek P M de Maat; Frank W G Leebeek
Journal:  Blood Rev       Date:  2014-04-22       Impact factor: 8.250

8.  ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.

Authors:  A C Papp; H Hatzakis; A Bracey; K K Wu
Journal:  Thromb Haemost       Date:  1989-02-28       Impact factor: 5.249

9.  Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  A R Folsom; K K Wu; E Shahar; C E Davis
Journal:  Arterioscler Thromb       Date:  1993-12

Review 10.  Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses.

Authors:  Peter Willeit; Alexander Thompson; Thor Aspelund; Ann Rumley; Gudny Eiriksdottir; Gordon Lowe; Vilmundur Gudnason; Emanuele Di Angelantonio
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240
  10 in total
  5 in total

1.  Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

Authors:  Margaret V Ragni
Journal:  Blood Adv       Date:  2017-04-25

2.  Berberine inhibits the ischemia-reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3-kinase/RAC-α serine/threonine-protein kinase and nuclear factor-κB signaling pathways.

Authors:  Lixin Wang; Hao Ma; Yan Xue; Haiyan Shi; Teng Ma; Xiaozheng Cui
Journal:  Exp Ther Med       Date:  2017-11-27       Impact factor: 2.447

3.  Prazosin protects myocardial cells against anoxia-reoxygenation injury via the extracellular signal‑regulated kinase signaling pathway.

Authors:  Lixin Wang; Yan Xue; Hao Ma; Haiyan Shi; Ling Wang; Xiaozheng Cui
Journal:  Mol Med Rep       Date:  2017-11-28       Impact factor: 2.952

4.  Whole-Genome Approach Discovers Novel Genetic and Nongenetic Variance Components Modulated by Lifestyle for Cardiovascular Health.

Authors:  Xuan Zhou; Julius van der Werf; Kristin Carson-Chahhoud; Guiyan Ni; John McGrath; Elina Hyppönen; S Hong Lee
Journal:  J Am Heart Assoc       Date:  2020-04-20       Impact factor: 5.501

5.  Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia.

Authors:  Melak Aynalem; Elias Shiferaw; Yemataw Gelaw; Bamlaku Enawgaw
Journal:  Thromb J       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.